WESTBROOK, Maine, Feb. 15, 2024 /CNW/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that seamlessly connects veterinary practices and clients through modern, digital tools. As the only pet owner engagement solution purpose-built for IDEXX practice management software, Vello enables veterinary practices using ezyVet®, Neo®, and Cornerstone® software to communicate efficiently with pet owners in a single, easy-to-use system. With software-supported engagement across the life stages of a pet, pet owners become informed partners in care—supporting better health outcomes. IDEXX's Vello solution will be available as a new subscription service for ezyVet, Neo, and Cornerstone software in the U.S. in March 2024 and Canada in Q2.
Veterinary professionals frequently cite client communication as one of the top challenges in achieving a more efficient practice,1 and 85% of practices indicate that poor integrations are a contributing factor to inefficiencies.2 Existing communication workflows are cumbersome, requiring frequent switching between phone calls, emails, and messaging solutions. Now, Vello software allows practices to engage with pet owners pre- and post-visit through an intuitive solution purpose-built for their practice management software.
"Practice productivity continues to be a top priority for veterinary clinics, and we are dedicated to delivering cloud-based software that creates efficiencies," said Jay Mazelsky, President and Chief Executive Officer of IDEXX. "With the Vello solution, practices can streamline workflows by managing pet owner communications within their existing practice management software, fostering stronger client relationships and improving care for pets."
The Vello solution includes a robust multi-year roadmap, with the following key features available at launch:
"Vello automates the way we engage with clients, eliminating duplicative administrative work, which has saved our team hours weekly and has significantly reduced no-shows and cancellations," said Dr. Kendall Snyder, Animal Care Clinic, North Canton, Ohio. "Since starting with Vello on ezyVet, my staff feels like they're partnering with the client so we can provide the best care possible for all of our patients—and our clients are loving the Vello experience too, from easy communication tools to having their pet's records just a click away."
For more information, please visit the Vello page, or visit the IDEXX Veterinary Software booth (#1021) at the WVC Annual Conference, taking place February 18-21, 2024, in Las Vegas, Nevada.
About IDEXX
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit: www.idexx.com.
Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as "expects," "may," "anticipates," "intends," "would," "will," "plans," "believes," "estimates," "should," "project," and similar words and expressions. These forward-looking statements are intended to provide our current expectations or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements. These statements are subject to risks, uncertainties, assumptions, and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of some of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are advised to review IDEXX's filings with the United States Securities and Exchange Commission (which are available from the SEC's EDGAR database at sec.gov and via IDEXX's website at idexx.com).
1 Today's Veterinary Practice, IDEXX UX Research, March 2021
2 Finding the Time: Empowering Veterinary Teams to Get the Most Out of Every Day, IDEXX publication: https://pages.idexx.com/practice-productivity_en-us
Last Trade: | US$411.28 |
Daily Change: | -3.65 -0.88 |
Daily Volume: | 94,468 |
Market Cap: | US$33.680B |
October 31, 2024 August 21, 2024 August 06, 2024 June 04, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB